Position in PBYI
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$10,862,574
+$4,361,759 QoQ
Shares Held
1,339,405
+31.7% QoQ
Ownership
2.59%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 160 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PBYI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. PBYI ranks #186 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in PBYI
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,862,574 | 1,339,405 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $6,500,815 | 1,017,342 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,916,352 | 994,345 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $5,222,501 | 983,522 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $3,332,841 | 971,674 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $2,828,148 | 955,456 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,804,276 | 919,435 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $2,339,285 | 917,367 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $3,097,475 | 950,146 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $2,400,746 | 452,971 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,922,719 | 444,046 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,119,104 | 425,515 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,399,277 | 396,396 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,210,111 | 391,622 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,611,253 | 380,911 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $887,958 | 374,666 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,054,759 | 370,091 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,726,312 | 599,414 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,937,367 | 637,292 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $4,256,128 | 607,151 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $5,701,936 | 621,126 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $5,855,211 | 602,388 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $5,400,238 | 526,339 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $5,427,259 | 537,885 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $5,496,765 | 527,015 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $3,987,368 | 472,437 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||